Murine humoral immune response against recombinant structural proteins of hepatitis C virus distinct from those of patients

Microbiology and Immunology

Volumn 40, Issue 2, 1996, Pages 169-176

  Ahmed, Mamun ^a   Shikata, Toshio ^a   Esumi, Mariko ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Antibody; Epitope; Hepatitis C virus; Structural protein

Indexed keywords

EPITOPE;

ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN;

HEPATITIS C VIRUS; MURINAE;

EID: 0030032636     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb03321.x     Document Type: Article

References (25)

1. Alter, H.J. 1989. Chronic consequences of non-A, non-B hepatitis, p. 83-97. In Seeff, L.B., and Lewis, J.H. (eds), Current perspective in hepatology, Plenum Medical, New York.
2. Chein, D.Y., Choo, Q.L., Ralston, R., Spaete, R., Tong, M., Houghton, M., and Kuo, G. 1993. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342: 933.
3. Chiba, J., Ohba, H., Matsuura, Y., Watanabe, Y., Katayama, T., Kikuchi, S., Saito, I., and Miyamura, T. 1991. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc. Natl. Acad. Sci. U.S.A. 88: 4641-4645.
4. Choo, Q.-L., Kuo, G., Weiner, A.J., Overy, L.R., Bradley, D.W., and Houghton, M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 21: 359-362.
5. Esumi, M., Hayashi, N., Takahashi, H., Shikata, T., Moriyama, M., Arakawa, Y., Eto, T., Nishihara, T., Nozaki, C., and Mizuno, K. 1995. Immunoreactive core peptides of hepatitis C virus produced in Escherichia coli and by DNA amplification-restricted transcription-translation system. J. Virol. Meth. in press.
6. Esumi, M., and Shikata, T. 1994. Hepatitis C virus and liver diseases. Pathol. Int. 44: 85-95.
7. Farci, P., Alter, H.J., Govindarajan, S., Wong, D.C., Engle, R., Lesniewski, R.R., Mushawar, I.K., Desai, S.M., Miler, H.R., Ogata, N., and Purcell, R.H. 1991. Lack of protective immunity against reinfection with hepatitis C virus. Science 258: 135-140.
8. Harada, S., Suzuki, R., Ando, A., Watanabe, Y., Yagi, S., Miyamura, T., and Saito, I. 1995. Establishment of a cell line constitutively expressing E2 glycoprotein of hepatitis C virus and humoral response of hepatitis C patients to the expressed protein. J. Gen. Virol. 76:1223-1231.
9. Hayashi, N., Higashi, K., Kaminaka, K., Sugimoto, H., Esumi, M., Komatsu, K., Hayashi, K., Sugitani, M., Suzuki, K., Okano, T., Nozaki, C., Mizuno, K., and Shikata, T. 1993. Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome. J. Hepatol. 17: s94-s104.
10. Hosein, B., Fang, C.T., Popovsky, M.A., Ye, J., Zhang, M., and Wang, C.Y. 1991. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc. Natl. Acad. Sci. U.S.A. 88: 3647-3651.
11. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T., and Shimotohno, K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U.S.A. 87: 9524-9528.
12. Kato, N., Sekiya, H., Ootsuyama, Y., Nakazawa, T., Hijikata, M., Ohkoshi, S., and Shimotohno, J. 1993. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 67: 3923-3930.
13. Kuo, G., Choo, Q.L., Alter, H.J., Gitnik, G.L., Redeker, A.G., Purcell, R.H., Miyamura, T., Dienstag, J.L., Alter, M.J., Stevens, C.E., Tegtmeier, G.E., Bonino, F., Colombo, W.S., Lee, W.S., Kuo, C., Berger, K., Shuster, J.R., Overby, L.R., Bradley, D.W., and Houghton, M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364.
14. Lanford, R.E., Notvall, L., Chavez, D., White, R., Frenzel, G., Simonsen, C., and Kim, J. 1993. Analysis of hepatitis C virus capsid, E1 and E2/NS1 proteins expressed in insect cells. Virology 197: 225-235.
15. Maeno, M., Kaminaka, K., Sugimoto, H., Esumi, M., Hayashi, N., Komatsu, K., Abe, K., Sekiguchi, S., Yano, M., Mizuno, K., and Shikata, T. 1990. A cDNA clone closely associated with non-A, non-B hepatitis. Nucleic Acids Res. 18: 2685-2689.
16. Mason, P.W., Pincus, S., Fournier, M.J., Mason, T.L., Shope, R.E., and Paolatti, E. 1991. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180: 294-305.
17. Mink, M.A., Benichou, P., Mandaule, P., Tiollais, P., Prince, A.M., and Inchauspe, G. 1994. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 200: 246-255.
18. Mishiro, S., Takeda, K., Hoshi, Y., Yoshikawa, A., Gotanda, T., and Itoh, Y. 1991. An auto antibody cross-reactive to hepatitis C virus core and a host nuclear antigen. Autoimmunity 10: 269-273.
19. Nasoff, M.S., Zebedee, S.L., Inchauspe, G., and Prince, M.A. 1991. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88: 5462-5466.
20. Nishihara, T., Nozaki, C., Nakatake, H., Hoshiko, K., Esumi, M., Hayashi, N., Hino, K., Hamada, F., Mizuno, K., and Shikata, T. 1993. Secretion and purification of hepatitis C virus NS1 glycoprotein produced by recombinant baculovirus-infected insect cells. Gene 129: 207-214.
21. Pincus, S., Mason, P.W., Konishi, E., Fonseca, B.A., Shope, R.E., Rice, C.M., and Paoletti, E. 1992. Recombinant vaccinia virus producing the preM and preE proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 187: 290-297.
22. Ray, R., Khanna, A., Lagging, L.M., Meyer, K., Choo, Q.-L., Ralstone, R., Houghton, M., and Bechere, P.R. 1994. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J. Virol. 68: 4420-4426.
23. Shimizu, K.Y., Hijikata, M., Iwamoto, A., Alter, J.H., Purcell, H.R., and Yoshikura, H. 1994. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68: 1494-1500.
24. Weiland, E., Stark, R., Haas, B., Rumenapf, T., Meyers, G., and Thiel, H.J. 1990. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfied linked heterodimer. J. Virol. 64: 3563-3569.
25. Weiner, A., Mario, G.H., Christopherson, C., Hall, E.J., Mason, T.J., Saracco, G., Bonino, F., Crawford, K., Marino, C.D., Crawford, K.A., Brunetto, M., Barr, P.J., Miyamura, T., McHutchinson, J., and Houghton, M. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. U.S.A. 89: 3468-3472.